Skip to main content
Log in

Nuclear translocation of β-catenin correlates with CD44 upregulation in Helicobacter pylori-infected gastric carcinoma

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Infection with Helicobacter pylori CagA-positive strains is associated with gastric adenocarcinoma. CagA H. pylori activates the β-catenin signal by translocation into nucleus which promotes carcinogenesis. Deregulated accumulation of nuclear β-catenin enhances transcription of β-catenin target genes including CD44 and promotes malignant transformation. The aim of this study was to investigate whether nuclear translocation of β-catenin correlates with CD44 expression in CagA H. pylori-infected gastric carcinoma. To address these issues, we examined 140 gastric biopsy specimens by using immunohistochemical and immunofluorescence staining, Western blot, and mutational analysis of the exon 3 β-catenin gene. The nuclear localization of β-catenin was significantly (χ2 = 21.175; P < 0.001) increased in advanced gastric carcinoma and also correlated (χ2 = 22.857; P < 0.001) with the CagA H. pylori positive specimens. We also observed that tyrosine-phosphorylated β-catenin was significantly (χ2 = 14.207; P < 0.001) increased in samples showing nuclear localization of β-catenin and also it correlated (χ2 = 43.69; P < 0.03) with the CagA H. pylori positive specimens. Exon 3 β-catenin gene mutation was not detected in H. pylori-infected gastric carcinoma. CD44 up regulation was significantly associated with tyrosine-phosphorylated β-catenin (χ2 = 22.5; P < 0.001), and this change was closely associated with nuclear translocation of β-catenin (χ2 = 13.393; P < 0.001) in CagA H. pylori-infected gastric carcinoma. In conclusion, our data suggest that CagA H. pylori infection is responsible for the tyrosine phosphorylation of β-catenin and its nuclear translocation, which upregulates β-catenin target gene CD44 in gastric carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Herrera V, Parsonnet J (2009) Helicobacter pylori and gastric adenocarcinoma. Clin Microbiol Infect 15:971–976. doi:10.1111/j.1469-0691.2009.03031.x

    Article  PubMed  CAS  Google Scholar 

  2. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A (1995) Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55:2111–2115

    PubMed  CAS  Google Scholar 

  3. Parsonnet J, Friedman GD, Orentreich N, Vogelman H (1997) Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40:297–301

    PubMed  CAS  Google Scholar 

  4. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R (2000) Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287:1497–1500

    Article  PubMed  CAS  Google Scholar 

  5. Higashi H, Nakaya A, Tsutsumi R, Yokoyama K, Fujii Y, Ishikawa S, Higuchi M, Takahashi A, Kurashima Y, Teishikata Y, Tanaka S, Azuma T, Hatakeyama M (2004) Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J Biol Chem 279:17205–17216. doi:10.1074/jbc.M309964200

    Article  PubMed  CAS  Google Scholar 

  6. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M (2002) SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295:683–686. doi:10.1126/science.1067147

    Article  PubMed  CAS  Google Scholar 

  7. Mimuro H, Suzuki T, Tanaka J, Asahi M, Haas R, Sasakawa C (2002) Grb2 is a key mediator of Helicobacter pylori CagA protein activities. Mol Cell 10:745–755. doi:10.1016/S1097276502006810

    Article  PubMed  CAS  Google Scholar 

  8. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S (2003) Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300:1430–1434. doi:10.1126/science.1081919

    Article  PubMed  CAS  Google Scholar 

  9. Churin Y, Al-Ghoul L, Kepp O, Meyer TF, Birchmeier W, Naumann M (2003) Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J Cell Biol 161:249–255. doi:10.1083/jcb.200208039

    Article  PubMed  CAS  Google Scholar 

  10. Murata-Kamiya N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Higashi H, Aburatani H, Akiyama T, Peek RM Jr, Azuma T, Hatakeyama M (2007) Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 26:4617–4626. doi:10.1038/sj.onc.1210251

    Article  PubMed  CAS  Google Scholar 

  11. Franco AT, Israel DA, Washington MK, Krishna U, Fox JG, Rogers AB, Neish AS, Collier-Hyams L, Perez-Perez GI, Hatakeyama M, Whitehead R, Gaus K, O’Brien DP, Romero-Gallo J, Peek RM Jr (2005) Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci USA 102:10646–10651. doi:10.1073/pnas.0504927102

    Article  PubMed  CAS  Google Scholar 

  12. Lilien J, Balsamo J, Arregui C, Xu G (2002) Turn-off, drop-out: functional state switching of cadherins. Dev Dyn 224:18–29. doi:10.1002/dvdy.10087

    Article  PubMed  CAS  Google Scholar 

  13. Nelson WJ, Nusse R (2004) Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303:1483–1487. doi:10.1126/science.1094291

    Article  PubMed  CAS  Google Scholar 

  14. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787–1790

    Article  PubMed  CAS  Google Scholar 

  15. Ilan N, Tucker A, Madri JA (2003) Vascular endothelial growth factor expression, beta-catenin tyrosine phosphorylation, and endothelial proliferative behavior: a pathway for transformation? Lab Invest 83:1105–1115

    Article  PubMed  CAS  Google Scholar 

  16. Clements WM, Wang J, Sarnaik A, Kim OJ, MacDonald J, Fenoglio-Preiser C, Groden J, Lowy AM (2002) Beta-catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res 62:3503–3506

    PubMed  CAS  Google Scholar 

  17. Ohene-Abuakwa Y, Noda M, Perenyi M, Kobayashi N, Kashima K, Hattori T, Pignatelli M (2000) Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer. J Pathol 192:433–439. doi:10.1002/1096-9896(2000)9999:9999<:AID-PATH723>3.0.CO;2-V

    Article  PubMed  CAS  Google Scholar 

  18. van de Wetering M, Cavallo R, Dooijes D, van Beest M, van Es J, Loureiro J, Ypma A, Hursh D, Jones T, Bejsovec A, Peifer M, Mortin M, Clevers H (1997) Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88:789–799

    Article  PubMed  Google Scholar 

  19. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382:638–642. doi:10.1038/382638a0

    Article  PubMed  CAS  Google Scholar 

  20. Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R, Clevers H, Pals ST (1999) Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 154:515–523. doi:10.1016/S0002-9440(10)65297-2

    Article  PubMed  CAS  Google Scholar 

  21. Hsieh HF, Yu JC, Ho LI, Chiu SC, Harn HJ (1999) Molecular studies into the role of CD44 variants in metastasis in gastric cancer. Mol Pathol 52:25–28

    Article  PubMed  CAS  Google Scholar 

  22. Li H, Guo L, Li JW, Liu N, Qi R, Liu J (2000) Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression. Int J Oncol 17:927–932

    PubMed  CAS  Google Scholar 

  23. Fan X, Long A, Goggins M, Keeling PW, Kelleher D (1996) Expression of CD44 and its variants on gastric epithelial cells of patients with Helicobacter pylori colonisation. Gut 38:507–512

    Article  PubMed  CAS  Google Scholar 

  24. Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49

    PubMed  CAS  Google Scholar 

  25. Udhayakumar G, Senthilkumar C, Jayanthi V, Devaraj N, Devaraj H (2009) Helicobacter pylori detection and genotyping in gastric biopsy specimens from Chennai patients (India). Can J Microbiol 55:126–132. doi:10.1139/w08-108

    Article  PubMed  CAS  Google Scholar 

  26. Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, Farthing MJ (1997) Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology 112:46–54

    Article  PubMed  CAS  Google Scholar 

  27. Udhayakumar G, Jayanthi V, Devaraj N, Devaraj H (2007) Interaction of MUC1 with beta-catenin modulates the Wnt target gene cyclinD1 in H. pylori-induced gastric cancer. Mol Carcinog 46:807–817. doi:10.1002/mc.20311

    Article  PubMed  CAS  Google Scholar 

  28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    PubMed  CAS  Google Scholar 

  29. Park WS, Oh RR, Park JY, Lee SH, Shin MS, Kim YS, Kim SY, Lee HK, Kim PJ, Oh ST, Yoo NJ, Lee JY (1999) Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. Cancer Res 59:4257–4260

    PubMed  CAS  Google Scholar 

  30. Takayama T, Shiozaki H, Doki Y, Oka H, Inoue M, Yamamoto M, Tamura S, Shibamoto S, Ito F, Monden M (1998) Aberrant expression and phosphorylation of beta-catenin in human colorectal cancer. Br J Cancer 77:605–613

    Article  PubMed  CAS  Google Scholar 

  31. Tsukashita S, Kushima R, Bamba M, Nakamura E, Mukaisho K, Sugihara H, Hattori T (2003) Beta-catenin expression in intramucosal neoplastic lesions of the stomach. Comparative analysis of adenoma/dysplasia, adenocarcinoma and signet-ring cell carcinoma. Oncology 64:251–258. doi:10.1159/000069310

    Article  PubMed  CAS  Google Scholar 

  32. Crawford HC, Krishna US, Israel DA, Matrisian LM, Washington MK, Peek RM Jr (2003) Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa. Gastroenterology 125:1125–1136. doi:10.1016/S001650850301206X

    Article  PubMed  CAS  Google Scholar 

  33. Fu S, Ramanujam KS, Wong A, Fantry GT, Drachenberg CB, James SP, Meltzer SJ, Wilson KT (1999) Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 116:1319–1329. doi:10.1016/S0016-5085(99)70496-8

    Article  PubMed  CAS  Google Scholar 

  34. Miehlke S, Yu J, Ebert M, Szokodi D, Vieth M, Kuhlisch E, Buchcik R, Schimmin W, Wehrmann U, Malfertheiner P, Ehninger G, Bayerdorffer E, Stolte M (2002) Expression of G1 phase cyclins in human gastric cancer and gastric mucosa of first-degree relatives. Dig Dis Sci 47:1248–1256

    Article  PubMed  CAS  Google Scholar 

  35. Nardone G, Staibano S, Rocco A, Mezza E, D’Armiento FP, Insabato L, Coppola A, Salvatore G, Lucariello A, Figura N, De Rosa G, Budillon G (1999) Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. Gut 44:789–799

    Article  PubMed  CAS  Google Scholar 

  36. Romano M, Ricci V, Memoli A, Tuccillo C, Di Popolo A, Sommi P, Acquaviva AM, Del Vecchio Blanco C, Bruni CB, Zarrilli R (1998) Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro. J Biol Chem 273:28560–28563

    Article  PubMed  CAS  Google Scholar 

  37. Sepulveda AR, Tao H, Carloni E, Sepulveda J, Graham DY, Peterson LE (2002) Screening of gene expression profiles in gastric epithelial cells induced by Helicobacter pylori using microarray analysis. Aliment Pharmacol Ther 16 Suppl 2:145–157

    Article  PubMed  CAS  Google Scholar 

  38. Yang Y, Deng CS, Peng JZ, Wong BC, Lam SK, Xia HH (2003) Effect of Helicobacter pylori on apoptosis and apoptosis related genes in gastric cancer cells. Mol Pathol 56:19–24

    Article  PubMed  CAS  Google Scholar 

  39. Piedra J, Martinez D, Castano J, Miravet S, Dunach M, de Herreros AG (2001) Regulation of beta-catenin structure and activity by tyrosine phosphorylation. J Biol Chem 276:20436–20443. doi:10.1074/jbc.M100194200

    Article  PubMed  CAS  Google Scholar 

  40. El-Etr SH, Mueller A, Tompkins LS, Falkow S, Merrell DS (2004) Phosphorylation-independent effects of CagA during interaction between Helicobacter pylori and T84 polarized monolayers. J Infect Dis 190:1516–1523. doi:10.1086/424526

    Article  PubMed  CAS  Google Scholar 

  41. Sokolova O, Bozko PM, Naumann M (2008) Helicobacter pylori suppresses glycogen synthase kinase 3beta to promote beta-catenin activity. J Biol Chem 283:29367–29374. doi:10.1074/jbc.M801818200

    Article  PubMed  CAS  Google Scholar 

  42. Wong SC, Lo ES, Lee KC, Chan JK, Hsiao WL (2004) Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer. Clin Cancer Res 10:1401–1408

    Article  PubMed  CAS  Google Scholar 

  43. Iwaya K, Ogawa H, Kuroda M, Izumi M, Ishida T, Mukai K (2003) Cytoplasmic and/or nuclear staining of beta-catenin is associated with lung metastasis. Clin Exp Metastasis 20:525–529

    Article  PubMed  CAS  Google Scholar 

  44. Giles RH, van Es JH, Clevers H (2003) Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653:1–24

    PubMed  CAS  Google Scholar 

  45. Saito A, Kanai Y, Maesawa C, Ochiai A, Torii A, Hirohashi S (1999) Disruption of E-cadherin-mediated cell adhesion systems in gastric cancers in young patients. Jpn J Cancer Res 90:993–999

    Article  PubMed  CAS  Google Scholar 

  46. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392:402–405. doi:10.1038/32918

    Article  PubMed  CAS  Google Scholar 

  47. Cao X, Tsukamoto T, Nozaki K, Mizoshita T, Ogasawara N, Tanaka H, Takenaka Y, Kaminishi M, Tatematsu M (2004) Beta-catenin gene alteration in glandular stomach adenocarcinomas in N-methyl-N-nitrosourea-treated and Helicobacter pylori-infected Mongolian gerbils. Cancer Sci 95:487–490

    Article  PubMed  CAS  Google Scholar 

  48. Kurashima Y, Murata-Kamiya N, Kikuchi K, Higashi H, Azuma T, Kondo S, Hatakeyama M (2008) Deregulation of beta-catenin signal by Helicobacter pylori CagA requires the CagA-multimerization sequence. Int J Cancer 122:823–831. doi:10.1002/ijc.23190

    Article  PubMed  CAS  Google Scholar 

  49. Cheng XX, Sun Y, Chen XY, Zhang KL, Kong QY, Liu J, Li H (2004) Frequent translocalization of beta-catenin in gastric cancers and its relevance to tumor progression. Oncol Rep 11:1201–1207

    PubMed  CAS  Google Scholar 

  50. Ougolkov AV, Yamashita K, Mai M, Minamoto T (2002) Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer. Gastroenterology 122:60–71

    Article  PubMed  CAS  Google Scholar 

  51. Odajima T, Sasaki Y, Tanaka N, Kato-Mori Y, Asanuma H, Ikeda T, Satoh M, Hiratsuka H, Tokino T, Sawada N (2005) Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features. Hum Pathol 36:234–241. doi:10.1016/j.humpath.2004.12.009

    Article  PubMed  CAS  Google Scholar 

  52. Seiter S, Arch R, Reber S, Komitowski D, Hofmann M, Ponta H, Herrlich P, Matzku S, Zoller M (1993) Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 177:443–455

    Article  PubMed  CAS  Google Scholar 

  53. Guo Y, Ma J, Wang J, Che X, Narula J, Bigby M, Wu M, Sy MS (1994) Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res 54:1561–1565

    PubMed  CAS  Google Scholar 

  54. Mayer B, Jauch KW, Gunthert U, Figdor CG, Schildberg FW, Funke I, Johnson JP (1993) De novo expression of CD44 and survival in gastric cancer. Lancet 342:1019–1022

    Article  PubMed  CAS  Google Scholar 

  55. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13–24

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Dr. Rajkumar, Dr. Revathi, and Dr. Murali for providing the gastric biopsy specimens. This study was supported by the grants from the UGC and the ICMR.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Halagowder Devaraj.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Udhayakumar, G., Jayanthi, V., Devaraj, N. et al. Nuclear translocation of β-catenin correlates with CD44 upregulation in Helicobacter pylori-infected gastric carcinoma. Mol Cell Biochem 357, 283–293 (2011). https://doi.org/10.1007/s11010-011-0899-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-011-0899-x

Keywords

Navigation